Interventional Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Diabetic Foot Wounds

Inclusion Criteria: * Diabetic patients, regardless of the age of their diabetes, with a grade UT 2 or 3 lower limb sore; grade 2: wound penetrating to the tendon or capsule. UT grade 3: wound penetrating to the bone or joint OR hospitalized/ambulatory patients for diabetic foot sores or amputations, which have not closed or are dehiscent. * Patients who can tolerate aggressive surgical debridement * Patients without severe ischemia IPS - 0.6 or pressure of the big toe - 50mmHg * Longness of the wound: 30 days (does not apply to amputation wounds; patients may be included when the wound is less than 30 days old) OR if the amputation level is under the ankle * Patients willing and able to give informed consent to participate in the clinical trial. * Male or female over the age of 18 * Patients living at a geographical distance compatible with referral nurse visits * Negative pregnancy test for women of childbearing age who do not use contraception. * Patients covered by social security * Patients who are capable (in the investigator's opinion) and willing to comply with all clinical trial requirements Exclusion Criteria: * Patients whose wound surface is not measurable * Patients with unsealed osteomyelitis * Patients with fever related to a foot infection (it may be reassessed at a later time when the infection is gone) * Patients with a necrotic wound that will not tolerate aggressive surgical debridement * Immunosuppressed patients * Patients with systemic corticosteroid…